Trial intelligence / Profile preview

Valproate and Levocarnitine in Children With Spinal Muscular Atrophy

NCT01671384Phase 3Unknown

Sponsor
AIIMS New Delhi
Start
Aug 2013
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of valproic acid in spinal muscular atrophy (SMA), sponsored by AIIMS New Delhi. Status: unknown.

02

Drugs

valproic acid
03

Conditions

spinal muscular atrophy (SMA)

Beyond the preview

Go deeper on NCT01671384.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01671384.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call